HCA Holdings, Inc. (NYSE:HCA) saw unusually large options trading activity on Thursday. Stock traders acquired 9,836 call options on the stock. This is an increase of approximately 1,863% compared to the average volume of 501 call options.

Shares of HCA (NYSE:HCA) opened at $84.05 on Friday. HCA has a twelve month low of $70.00 and a twelve month high of $91.03. The stock has a market cap of $29,758.16, a price-to-earnings ratio of 12.75, a P/E/G ratio of 1.23 and a beta of 0.55. The company has a current ratio of 1.68, a quick ratio of 1.41 and a debt-to-equity ratio of -6.46.

HCA (NYSE:HCA) last announced its quarterly earnings results on Tuesday, October 31st. The company reported $1.21 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $1.21. HCA had a net margin of 6.13% and a negative return on equity of 47.16%. The firm had revenue of $10.70 billion for the quarter, compared to the consensus estimate of $10.70 billion. During the same period in the prior year, the firm posted $1.45 earnings per share. The firm’s quarterly revenue was up 4.1% compared to the same quarter last year. analysts anticipate that HCA will post 6.56 EPS for the current fiscal year.

In other HCA news, SVP Victor L. Campbell sold 8,000 shares of the business’s stock in a transaction that occurred on Thursday, November 16th. The shares were sold at an average price of $75.82, for a total transaction of $606,560.00. Following the sale, the senior vice president now owns 127,275 shares of the company’s stock, valued at approximately $9,649,990.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Michael S. Cuffe sold 2,150 shares of the business’s stock in a transaction that occurred on Wednesday, November 22nd. The stock was sold at an average price of $78.00, for a total transaction of $167,700.00. Following the sale, the insider now directly owns 12,476 shares in the company, valued at approximately $973,128. The disclosure for this sale can be found here. In the last three months, insiders have sold 22,450 shares of company stock worth $1,737,681. 2.90% of the stock is owned by insiders.

A number of hedge funds and other institutional investors have recently made changes to their positions in HCA. Longview Partners Guernsey LTD boosted its holdings in HCA by 22.6% during the third quarter. Longview Partners Guernsey LTD now owns 11,135,155 shares of the company’s stock worth $886,247,000 after buying an additional 2,053,701 shares in the last quarter. APG Asset Management N.V. boosted its holdings in HCA by 141.4% during the third quarter. APG Asset Management N.V. now owns 3,423,381 shares of the company’s stock worth $272,467,000 after buying an additional 2,005,193 shares in the last quarter. Assenagon Asset Management S.A. boosted its holdings in HCA by 1,500.3% during the third quarter. Assenagon Asset Management S.A. now owns 1,579,382 shares of the company’s stock worth $125,703,000 after buying an additional 1,480,690 shares in the last quarter. Harbour Capital Advisors LLC boosted its holdings in HCA by 9,568.4% during the second quarter. Harbour Capital Advisors LLC now owns 915,600 shares of the company’s stock worth $10,500,000 after buying an additional 906,130 shares in the last quarter. Finally, American Century Companies Inc. boosted its holdings in HCA by 49.5% during the third quarter. American Century Companies Inc. now owns 2,558,216 shares of the company’s stock worth $203,608,000 after buying an additional 847,377 shares in the last quarter. 75.35% of the stock is currently owned by hedge funds and other institutional investors.

Several research firms have recently commented on HCA. Argus dropped their price objective on shares of HCA from $100.00 to $93.00 and set a “buy” rating on the stock in a report on Monday, August 14th. Zacks Investment Research raised shares of HCA from a “sell” rating to a “hold” rating in a report on Tuesday, August 8th. KeyCorp reaffirmed an “overweight” rating and issued a $90.00 price objective (down from $95.00) on shares of HCA in a report on Thursday, October 19th. ValuEngine raised shares of HCA from a “hold” rating to a “buy” rating in a report on Thursday. Finally, Morgan Stanley dropped their price objective on shares of HCA from $88.00 to $85.00 and set an “equal weight” rating on the stock in a report on Thursday, August 17th. Two research analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $90.20.

ILLEGAL ACTIVITY NOTICE: This piece was published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/12/03/investors-purchase-large-volume-of-hca-call-options-hca.html.

HCA Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.